---
title: "Exozymes prices registered direct offering at USD 18 per unit, raising USD 639,990 gross"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291459539.md"
description: "Exozymes priced a direct offering of 35,555 units at $18 each, raising $639,990 in gross proceeds. Each unit includes two common shares and one warrant with an $11.24 strike price. Net proceeds are earmarked for NCT development, R&D, and corporate uses. Placement agent MDB Capital received a commission and warrants."
datetime: "2026-07-01T20:32:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291459539.md)
  - [en](https://longbridge.com/en/news/291459539.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291459539.md)
generator: "portal-rs"
---

# Exozymes prices registered direct offering at USD 18 per unit, raising USD 639,990 gross

-   Exozymes priced a placement of 35,555 units at USD 18 per unit, each with two common shares and one warrant. \* Deal issued 71,110 shares, 35,555 warrants; gross proceeds USD 639,990, net proceeds earmarked for NCT development, R&D, corporate uses. \* Placement agent MDB Capital earned USD 44,799 commission; received a warrant for 10,666 shares at USD 11.24, exercisable Dec. 30, 2026. \* Investor warrants carry a USD 11.24 strike; become exercisable June 5, 2027; expire June 5, 2031; redemption possible if shares trade at USD 17.98. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031560), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [EXOZ.US](https://longbridge.com/en/quote/EXOZ.US.md)
- [MDBH.US](https://longbridge.com/en/quote/MDBH.US.md)

## Related News & Research

- [eXoZymes selects Curia as commercial-scale manufacturing partner for NCT](https://longbridge.com/en/news/298464153.md)
- [Curia partners with eXoZymes to scale up NCT manufacturing process](https://longbridge.com/en/news/298343956.md)
- [Conexeu Sciences issues 762,608 unregistered shares at US$2.3 in warrant exercise incentive program](https://longbridge.com/en/news/298641692.md)
- [Precise Biometrics sets warrant exercise price at SEK 0.47 per share](https://longbridge.com/en/news/298683825.md)
- [Cyabra issues 24,505,747 pre-funded warrants in unregistered exchange valued at $10.66 million](https://longbridge.com/en/news/298575303.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**